Phase 1 Type 2 Diabetes Trial, Recruiting NCT06596967 Sponsor: Purdue University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 1 Type 2 Diabetes Trial, Recruiting

NCT06596967
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 55 years of age or older
  • You have been diagnosed with Type 2 Diabetes, confirmed by medical records, current diabetes treatment, a fasting blood sugar level of 126 mg/dL or higher, or an A1C test result of 6.5% or higher

Who may not be able to join:

  • Your A1C (a measure of blood sugar control) is below 6.5% or above 9.0%
  • Your body mass index (BMI) is above 40 (confirm with trial site)
  • You have Type 1 Diabetes and rely on insulin
  • You have had a heart attack or stroke in the past year
  • You have active symptoms of heart disease or heart failure
  • Your blood pressure is uncontrolled, with a top number above 150 or a bottom number above 110
  • Your resting blood pressure top number is below 90 (abnormally low blood pressure)
  • You use a mobility aid other than a standard cane (for example, a walker or wheelchair)
  • You currently have an active cancer diagnosis
  • You have reduced or impaired ability to feel temperature sensations in your legs
  • You are unable to be fitted into the water-circulating garments used in the study
  • You have a bone or joint condition that would prevent you from completing physical movement tests
  • You are unable to have a DXA scan (a type of body composition scan), for example due to implants, medical devices, or difficulty lying still during the scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Purdue University
Registry
ClinicalTrials.gov
Start date
3 September 2024
Est. completion
31 July 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Compliance; Completion rate; Safety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov